Market News AIOpen the app

CURX stock news · Curanex Pharmaceuticals

Stories about Curanex Pharmaceuticals (CURX) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for CURX

Follow Curanex Pharmaceuticals (CURX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for CURX
Free on the App Store and Google Play, or on the web.
  1. Nov 14, 2026, 9:07 AM ET · Market

    Curanex Pharmaceuticals showed no sales and a bigger loss in the third quarter of 2026.

    Bad for CURX

    Curanex's operating loss grew to $2.82 million from $0.95 million, and its loss per share widened to $1.86 from $0.75. This points to a weaker outlook.